Do you need to get your patient with myeloma into CR prior to autologous transplant?
Answers to this and many other key questions in newly diagnosed myeloma with the eloquent and wise @VincentRK on @BloodCancerTalk - wherever you get your podcasts
#mmsm#myeloma@rajshekharucms
🎙️ New @BloodCancerTalks episode is live!
We sat down with the legendary @VincentRK to discuss newly diagnosed #MultipleMyeloma — diagnosis, risk stratification, induction, when to transplant, and maintenance!
share.transistor.fm/s/85832e…
Our 1st episode of 2026 just dropped! MajesTEC-3 and the Bispecific Revolution!
First author @LucianoCostaMD walks us through the nuts and bolts of the data and how BCMA BsAbs will disrupt the treatment paradigm at early relapse!
share.transistor.fm/s/7f2b38…#ASH25#mmsm
Tune in to our new episode on International #Myeloma Society 2025 Updates with key abstracts ranging from smoldering myeloma to relapsed/refractory myeloma with @AlGarfall!
tinyurl.com/rc764yrh
🎧 NEW EPISODE ALERT! 🎧
Dive deep into follicular lymphoma management with Dr. Gilles Salles @MSKCancerCenter! From watchful waiting to bispecifics & CAR-T - we cover it all.
🔬 Key trials: RELEVANCE, GALLIUM, InMIND & more
Listen now! 🎙️
@Eddie_Cliffshare.transistor.fm/s/4fba38…
Shamelessly stealing the concept of emergency podcasts from @RestIsPolitics but don’t worry we aren’t talking politics - we talk AQUILA, STARGLO, FDA ODAC
Come into the weeds of clinical trials with us
Glofitamab-GemOx for R/R DLBCL
#starglo#lymsm#ODAC@csoncol@OncoAlert
New🚨 EMERGENCY PODCAST 🚨 episode @BloodCancerTalk!
Following recent FDA ODAC proceedings, we dissect two pivotal trials & insights from FDA/panelists:
🔸 AQUILA: Daratumumab in high-risk SMM
🔸 STARGLO: Glofitamab in R/R DLBCL
share.transistor.fm/s/bb6152…
A short clip on STARGLO: